Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence Study

Table 6

ANOVARM models on cognitive domains.

		Treatment	Visit	TreatmentVisit
		p-value	p-value	p-value
Psychomotor speed	Non imputed	0.1776	0.3640	0.0976
	LOCF	0.2523	0.6886	0.6286
Memory performance	Non imputed	0.3744	0.0603	0.8072
	LOCF	0.6512	0.0011	0.3446
Global cognitive index	Non imputed	0.8449	0.1548	0.9128
	LOCF	0.9332	<0.0001	0.8932
General cognitive evaluation	Non imputed	0.6969	0.3913	0.5367
	LOCF	0.9861	0.0201	0.3556
Episodic memory	Non imputed	0.9032	0.3466	0.6365
	LOCF	0.4948	0.0967	0.3351
Short-term memory	Non imputed	0.2731	0.9264	0.9663
	LOCF	0.4543	0.9630	0.5808
Executive functions	Non imputed	0.8123	0.6211	0.5504
	LOCF	0.0952	0.8617	0.4169
Language	Non imputed	0.2712	0.9891	0.9413
	LOCF	0.6422	0.7070	0.8942
Problem solving	Non imputed	0.7387	0.7072	0.3618
	LOCF	0.8405	0.0224	0.0677
Dementia staging	Non imputed	0.5226	0.1699	0.5337
	LOCF	0.6445	0.7873	0.4778
Daily living activities	Non imputed	0.4063	0.9233	0.9826
	LOCF	0.1288	0.9979	0.3036
Major psychiatric disorders	Non imputed	0.1139	0.3879	0.1515
	LOCF	0.1028	0.0079	0.4263